BIYKEM BOZKURT to Mineralocorticoid Receptor Antagonists
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Mineralocorticoid Receptor Antagonists.
Connection Strength
1.175
-
European Journal of Heart Failure International Expert Position Paper-Utilization, optimization, and clinical benefits of steroidal mineralocorticoid receptor antagonists in heart failure with a reduced ejection fraction. Eur J Heart Fail. 2026 Sep 15; 28(3):513-534.
Score: 0.241
-
Management of patients with heart failure at high risk of hyperkalaemia: The CARE-HK in HF registry. Eur J Heart Fail. 2025 Nov; 27(11):2410-2421.
Score: 0.223
-
Mortality, Outcomes, Costs, and Use of?Medicines Following a First Heart?Failure?Hospitalization: EVOLUTION HF. JACC Heart Fail. 2023 10; 11(10):1320-1332.
Score: 0.192
-
Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines. J Am Coll Cardiol. 2003 Jan 15; 41(2):211-4.
Score: 0.187
-
WORSENING RENAL FUNCTION IN ACUTE DECOMPENSATED HEART FAILURE: A BAD SIGN, OR MAYBE NOT? Trans Am Clin Climatol Assoc. 2019; 130:41-50.
Score: 0.141
-
Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). J Card Fail. 2011 Aug; 17(8):634-42.
Score: 0.083
-
Prevention of heart failure after acute myocardial infarction. Lancet. 2025 09 13; 406(10508):1154-1170.
Score: 0.056
-
Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry. J Card Fail. 2025 06; 31(6):881-891.
Score: 0.052